摘要
目的:分析中西医结合治疗严重急性呼吸综合征的疗效。方法:对2003年3月11日～4月30日在我院住院治疗的112例SARS患者进行分析。结果:中西医结合治疗73例,其中普通型60例,治愈51例(85％),无1例死亡;重型13例,治愈9例(69.2％),死亡2例。西药治疗39例,其中普通型20例,治愈13例(65％);重型19例,死亡9例(47.4%),与中西医结合治疗相比较,差异具有显著性(P<0.05)。免疫功能检测:中西医结合治疗后,普通型病人CD_4^+T淋巴细胞由324±179/mm^3上升到786±360/mm^3(P<0.05),重型患者CD_4^+T由357±311/mm^3上升到445±332/mm^3(P<0.05)。单纯西药治疗组:普通型病人CD_4^+T淋巴细胞由343±254/mm^3上升到451±408/mm^3(P<0.05),重型患者CD_4^+T淋巴细胞由229±69/mm^3下降到205±108/mm^3(P>0.05)。结论:与单纯西药治疗相比较,中西医结合治疗能显著改善SARS患者的预后,降低患者的死亡率;同时能帮助患者恢复免疫功能。
Aim: To evaluate the effect of therapy of integrated Chinese medicine with western medicine on severe a-cute respiratory syndrome. Method: 112 cases of SARS from 11 March to 30 April, 2003 were analyzed. Results: 73 cases were treated with the therapy of integrated Chinese medicine with western medicine in which 51 cases (58%) were cured and no death occurred in 60 mild cases. 9 cases (69.2%) were cured and 2 cases died in 13 severe cases. In total 39 cases treated by western medicine, 13 cases (65%) were cured in 20 mild cases and 9 cases (47.4%) died in 19 severe cases. The difference is significant ( P < 0.05) compared with the group of the therapy of integrated Chinese medicine with western medicine. Immunity function test: CD4 + T count from 324 ± 179/mm3 up to 786 ± 3607mm3( P
< 0.05) in mild cases and from 357 ± 311/mm3 to 445± 332/mm3( P < 0.05) in severe cases in the group of the therapy of integrated Chinese medicine with western medicine, CD4 + T count from 343 ± 254/mm3 up to 451 ± 408/mm3 ( P
< 0.05) in mild cases and from 229± 69/mm down to 205 ± 108/mm (P > 0.05) in severe cases in the group of the therapy of western medicine only. Conclusion: Therapy of integrated Chinese medicine with western medicine can markedly improve prognosis and reduce the mortality of SARS compared with therapy of western medicine only. It also can improve immunity of SARS patients.
出处
《中国医药学报》
CSCD
2003年第6期326-328,共3页
China Journal of Traditional Chinese Medicine and Pharmacy
